World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
59
Citations
11714
World Ranking
3288
National Ranking
186

Sophie Matheron publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Sophie Matheron sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 278 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Sophie Matheron D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Sophie Matheron sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 59 D-Index — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Sophie Matheron is affiliated with Université Paris Cité in France and has a focused research profile within the fields of Medicine and Immunology and Microbiology. Their work covers various subfields including Infectious Diseases, Virology, Immunology, Public Health, Environmental and Occupational Health, and Emergency Medicine.

Their research spans important topics such as HIV Research and Treatment, HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, HIV-related health complications and treatments, Parasites and Host Interactions, Antibiotic Resistance in Bacteria, and Malaria Research and Control.

Notable recent publications authored or coauthored by Sophie Matheron include:

  • Imported loiasis in France: a retrospective analysis of 167 cases with comparison between sub-Saharan and non sub-Saharan African patients, 2020, BMC Infectious Diseases
  • Hygiene promotion might be better than serological screening to deal with Cytomegalovirus infection during pregnancy: a methodological appraisal and decision analysis, 2020, BMC Infectious Diseases
  • Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers, 2022, Nature Communications
  • Risk of birth defects and perinatal outcomes in HIV-infected women exposed to integrase strand inhibitors during pregnancy, 2020, AIDS
  • Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohort, 2023, Journal of Antimicrobial Chemotherapy

Sophie Matheron frequently collaborates with several researchers including Diane Descamps, Gilles Peytavin, Brigitte Autran, Jean-Michel Molina, and Florence Damond, each having coauthored multiple publications together.

Their publications are primarily featured in journals such as:

  • Journal of Antimicrobial Chemotherapy
  • AIDS
  • Clinical Infectious Diseases
  • BMC Infectious Diseases
  • Research Square

This profile captures an active and ongoing research involvement at the intersection of infectious diseases, immunology, and public health, with a significant contribution to the understanding and treatment of HIV/AIDS and related health complications.

Best Publications

  • Evidence of Sexual Transmission of Zika Virus

    Eric D'Ortenzio;Sophie Matheron;Yazdan Yazdanpanah;Xavier de Lamballerie

  • The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.

    Vincent Di Martino;Pierre Rufat;Nathalie Boyer;Philippe Renard

  • No Perinatal HIV-1 Transmission From Women With Effective Antiretroviral Therapy Starting Before Conception

    Laurent Mandelbrot;Roland Tubiana;Jerome Le Chenadec;Catherine Dollfus

  • Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome: Efficacy of long-term continuous therapy

    Catherine Leport;Francois Raffi;Sophie Matheron;Christine Katlama

  • Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial.

    Jean-Luc Meynard;Muriel Vray;Laurence Morand-Joubert;Esther Race

  • High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics

    Etienne Ruppé;Etienne Ruppé;Laurence Armand-Lefèvre;Laurence Armand-Lefèvre;Candice Estellat;Candice Estellat;Paul-Henri Consigny

  • EFFECTS OF ZIDOVUDINE IN 365 CONSECUTIVE PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX

    E. Dournon;W. Rozenbaum;C. Michon;C. Perronne

  • Cellular and plasma viral load in patients infected with HIV-2

    F Simon;S Matheron;C Tamalet;I Loussert-Ajaka

  • Identification of a Highly Divergent HIV Type 2 and Proposal for a Change in HIV Type 2 Classification

    Florence Damond;Michael Worobey;Pauline Campa;Isabelle Farfara

  • Efficacy and Tolerance of Intravitreal Ganciclovir in Cytomegalovirus Retinitis in Acquired Immune Deficiency Syndrome

    Isabelle Cochereau-Massin;Phuc Lehoang;Marie Lautier-Frau;Lydie Zazoun

  • HIV-2/LAV-2 in Portuguese man with AIDS (Paris, 1978) who had served in Angola in 1968-74

    A.G. Saimot;J.P. Coulaud;D. Mechali;S. Matheron

  • Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus–1 transmission in France

    Marie-Jeanne Mayaux;Jean-Paul Teglas;Laurent Mandelbrot;Alain Berrebi

  • Resting energy expenditure in human immunodeficiency virus-infected patients: comparison between patients with and without secondary infections.

    J C Melchior;G Raguin;A Boulier;E Bouvet

  • Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations.

    Lise Musset;Olivier Bouchaud;Sophie Matheron;Laurent Massias

  • Hiv-2 molecular epidemiology

    Benoit Visseaux;Benoit Visseaux;Florence Damond;Sophie Matheron;Diane Descamps

  • Foscarnet in the Treatment of Cytomegalovirus Retinitis in Acquired Immune Deficiency Syndrome

    Phuc Lehoang;Brigitte Girard;Martin Robinet;Patricia Marcel

  • HERS AFTER A WILD RODENT BITE IN THE HAUTE-SAVOIE—AND RISK OF EXPOSURE TO HANTAAN-UKE VIRUS IN A PARIS LABORATORY

    E. Dournon;B. Moriniere;S. Matheron;P. M. Girard

  • In Vitro Phenotypic Susceptibility of Human Immunodeficiency Virus Type 2 Clinical Isolates to Protease Inhibitors

    Delphine Desbois;Bénédicte Roquebert;Gilles Peytavin;Florence Damond

  • HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitro

    B. Roquebert;B. Roquebert;F. Damond;G. Collin;S. Matheron

  • Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort.

    Sophie Matheron;Sophie Pueyo;Florence Damond;Francois Simon

Frequent Co-Authors

Françoise Brun-Vézinet
Françoise Brun-Vézinet Université Paris Cité
Geneviève Chêne
Geneviève Chêne University of Bordeaux
Gilles Peytavin
Gilles Peytavin Claude Bernard University Lyon 1
François Simon
François Simon Université Paris Cité
Christine Katlama
Christine Katlama Sorbonne University
Florence Damond
Florence Damond Hôpital Bichat-Claude-Bernard
Rodolphe Thiébaut
Rodolphe Thiébaut University of Bordeaux
André Cabié
André Cabié Grenoble Alpes University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career paths beyond traditional laboratory roles. One growing field is health information management, where professionals combine healthcare knowledge with data management skills. For those interested, exploring the best online cahiim accredited health information management degree programs can offer a flexible path to enter this in-demand sector.

Another viable option is medical coding and billing, essential for managing healthcare finances and records. Those aiming to start quickly might consider the fastest online medical billing and coding certificate programs, which provide certification in a short time frame to launch your career.

Certified Professional Coders enjoy competitive compensation, making cpc certification salary insights crucial for evaluating this career’s financial prospects. Additionally, experienced professionals can advance into leadership roles such as health information managers, whose roles are pivotal in healthcare data governance and who command attractive packages, detailed under health information manager salary.

Integrating microbiology expertise with health information and coding credentials can greatly enhance career opportunities in healthcare and research sectors.

Best Scientists Citing Sophie Matheron

Trending Scientists

Recently Published Articles